CD34 and prostate carcinoma: In several studies, resveratrol treatment blocked nuclear translocation of the p65 subunit of NF-κB in myeloid U-937 cells [38], in TNF-induced prostate cancer PC-3 cells [39], and in human CD34+ cells [40].